# Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: Boehringer Ingelheim · Condition: Solid Tumours

- Company: Boehringer Ingelheim
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06581432

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.